Back to Journals » Clinical Ophthalmology » Volume 10

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”

Authors Kaya A

Received 12 March 2016

Accepted for publication 15 March 2016

Published 18 April 2016 Volume 2016:10 Pages 695—696

DOI https://doi.org/10.2147/OPTH.S108314

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser


Abdullah Kaya

Department of Ophthalmology, Anittepe Military Dispensary, Ankara, Turkey

I read the current article titled “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes” by Razi et al,1 with great interest.

View the original article by Razi et al

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]